Release time：2025-03-02 Source：Xurui Biotechnology
On January 10th, the company obtained three product medical device registration certificates (in vitro diagnostic reagents) for β 2-microglobulin (β 2-MG) detection kit (fluorescence immunoassay) (E-Xie Zhuzhun 20252405361), urine microalbumin (MAU) detection kit (fluorescence immunoassay) (E-Xie Zhuzhun 20252405359), and retinol binding protein (RBP) detection kit (fluorescence immunoassay) (E-Xie Zhuzhun 20252405360).
